Dunhill Financial’s Amicus Therapeutics FOLD Stock Holding History

Dunhill Financial’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$76	–	1729
2026 Q1	$76	Hold	5	–	–	﹤0.01%	1500
2025 Q4	$76	Buy	+5	New	+$49	﹤0.01%	1495

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Dunhill Financial's FOLD Position: Q2 2026 in Review

Dunhill Financial sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 5 shares — an estimated $76 sold.

Dunhill Financial first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $76 in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Dunhill Financial reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Dunhill Financial sold 5 Amicus Therapeutics shares in Q2 2026, an estimated $76.
Dunhill Financial first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Dunhill Financial's Amicus Therapeutics position peaked at $76 in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.